EGCG-Zn Encapsulated in Plasma-Derived Gel with Enhanced Antibacterial, Anti-Inflammatory, and Osteogenic Effects for the Therapy of Periodontitis
ACS Biomaterials Science & Engineering · 2026
DOI: 10.1021/acsbiomaterials.5c01515 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Biomaterials Science & Engineering, 2026. Verfasst von Qiurui Hu und 12 weiteren Autor:innen. Beteiligte Einrichtung: Guangxi Key Laboratory of Oral and Maxillofacial Rehabilitation and Reconstruction, College & Hospital of Stomatology, Guangxi Medical University, Na…. Hauptthemen laut MEDLINE: Periodontitis, Catechin, Zinc, Anti-Bacterial Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 57 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Guangxi Medical and Health Suitable Technology Development and Popularization Application Project, Joint Project on Regional High-Incidence Diseases Research of Guangxi Natural Science Foundation.
Abstract (Originalsprache)
The optimal therapeutic strategy for periodontitis aims to eliminate pathogenic bacteria within periodontal pockets while promoting periodontal tissue regeneration. However, treatment efficacy remains limited due to anatomical constraints within the periodontal environment. Furthermore, antibiotic resistance presents a persistent challenge in clinical management, notwithstanding the status of antibiotics as first-line therapeutics. To thoroughly eliminate bacteria and reduce drug resistance, we prepared a polyphenol-metal coordination hydrogel, namely EGCG-Zn@FG, which consists of a plasma-derived fibrin gel wrapped with epigallocatechin gallate (EGCG) coordinated with zinc ions. The antibacterial efficacy was synergistically enhanced by the intrinsic antimicrobial properties of EGCG combined with the sustained release of zinc ions. Of particular note, EGCG-Zn@FG demonstrated superior antibacterial activity against Porphyromonas gingivalis compared to EGCG-Zn alone. Meanwhile, EGCG-Zn@FG was also shown to have anti-inflammatory effects by reducing the expression of inflammatory factors (IL-1β and IL-6). It is worth mentioning that EGCG-Zn@FG was also verified to upregulate the expression of osteogenic factors (Col-1, ALP, and Runx-2) through the release of EGCG, promoting alveolar bone repair. In rat models, EGCG-Zn@FG in the treatment area was slowly and continuously released for 24 h after administration. Notably, the administration of EGCG-Zn@FG not only exhibited remarkable capability in mitigating dental inflammation and facilitating bone repair, but also ensured favorable biosafety in periodontitis rat models, thereby highlighting its dual advantages in therapeutic efficacy and biocompatibility. Collectively, these findings validate EGCG-Zn@FG as a promising antibiotic-alternative strategy to address antibiotic resistance in periodontitis while possessing substantial potential for clinical treatment of periodontal disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Guangxi Key Laboratory of Oral and Maxillofacial Rehabilitation and Reconstruction, College & Hospital of Stomatology, Guangxi Medical University, Nanning 530021, China.
- Prosthodontics Department, College & Hospital of Stomatology, Guangxi Medical University, Nanning 530021, China.
- Experimental Research Department, College & Hospital of Stomatology and Clinical Laboratory Medicine Department, Guangxi Medical University, Nanning 530021, China.
- Clinical Laboratory Medicine Department, College & Hospital of Stomatology, Guangxi Medical University, Nanning, Guangxi 530021, China.
ORCID-Profile: Xiaojie Li, Xinglu Jiang
Förderung
- National Natural Science Foundation of China
- Guangxi Medical and Health Suitable Technology Development and Popularization Application Project
- Joint Project on Regional High-Incidence Diseases Research of Guangxi Natural Science Foundation
- Guangxi Key Laboratory of the Rehabilitation and Reconstruction for Oral and Maxillofacial Research open project
Zitieren
APA
Hu, Q., Huang, Y., Liang, H., Huang, X., Li, X., Chen, L., Liang, L., Lu, Q., Zhou, G., Su, X., Li, C., Li, X., & Jiang, X. (2026). EGCG-Zn Encapsulated in Plasma-Derived Gel with Enhanced Antibacterial, Anti-Inflammatory, and Osteogenic Effects for the Therapy of Periodontitis. ACS Biomaterials Science & Engineering. https://doi.org/10.1021/acsbiomaterials.5c01515
Vancouver
Hu Q, Huang Y, Liang H, Huang X, Li X, Chen L, et al. EGCG-Zn Encapsulated in Plasma-Derived Gel with Enhanced Antibacterial, Anti-Inflammatory, and Osteogenic Effects for the Therapy of Periodontitis. ACS Biomaterials Science & Engineering. 2026. doi:10.1021/acsbiomaterials.5c01515
BibTeX
@article{Hu2026,
author = {Hu, Qiurui and Huang, Yonghui and Liang, Hao and Huang, Xianxian and Li, Xiaowen and Chen, Li and Liang, Lingling and Lu, Qinglan and Zhou, Guangqi and Su, Xiaoping and Li, Cuiping and Li, Xiaojie and Jiang, Xinglu},
title = {EGCG-Zn Encapsulated in Plasma-Derived Gel with Enhanced Antibacterial, Anti-Inflammatory, and Osteogenic Effects for the Therapy of Periodontitis},
journal = {ACS Biomaterials Science & Engineering},
year = {2026},
doi = {10.1021/acsbiomaterials.5c01515}
}
EUVIMED